Press Releases
2023 – Press Releases
NetraMark Closes Private Placement Financing
September 19, 2023 | NetraMark Holdings
Pharmaceutical Industry Veteran Joins NetraMark Advisory Board
July 19, 2023 | NetraMark Holdings
NetraMark Announces Engagement of ARU Global Inc.
June 21, 2023 | NetraMark Holdings
NetraMark Announces Uplist to the OTCQB Market
June 7, 2023 | NetraMark Holdings
NetraMark to Attend American Society of Clinical Oncology Conference in Chicago
June 1, 2023 | NetraMark Holdings
NetraMark engages ITG as Market Maker to enhance liquidity
May 9, 2023 | NetraMark Holdings
NetraMark Announces Closing of Private Placement
March 24, 2023 | NetraMark Holdings
NetraMark Releases Paper Demonstrating AI Capabilities to Derive Insights Using Clinical Scale Data
February 27, 2023 | NetraMark Holdings
NetraMark Private Placement – Press Release Clarification
September 15, 2023 | NetraMark Holdings
NetraMark Announces Shares for Debt Settlement
July 5, 2023 | NetraMark Holdings
NetraMark Closes Second and Final Tranche of Private Placement
June 14, 2023 | NetraMark Holdings
NetraMark Announces Increase to Private Placement Financing
June 6, 2023 | NetraMark Holdings
NetraMark to Participate in Renmark’s Virtual Non-Deal Roadshow
May 30, 2023 | NetraMark Holdings
NetraMark retains Renmark Financial Communications Inc.
May 5, 2023 | NetraMark Holdings
Healthcare Strategy Leader Joins NetraMark Advisory Board
March 21, 2023 | NetraMark Holdings
Introducing NetraMark – A Pharma AI Company
January 30, 2023 | NetraMark Holdings
NetraMark Announces Private Placement Financing
September 11, 2023 | NetraMark Holdings
NetraMark Enters into Advisor Agreement
June 22, 2023 | NetraMark Holdings
NetraMark Closes First Tranche of Private Placement
June 9, 2023 | NetraMark Holdings
NetraMark Announces Private Placement Financing
June 1, 2023 | NetraMark Holdings
NetraMark, the First Public AI Company to Launch Clinical Trial De-Risking Technology that Integrates ChatGPT
May 16, 2023 | NetraMark Holdings
NetraMark Successfully Delivers on Biopharma Client Contract
May 2, 2023 | NetraMark Holdings
NetraMark Uncovers Unique Alzheimer’s Disease Subtypes
March 15, 2023 | NetraMark Holdings